Neofect "Wibrain Integrates AI Technology into Electronic Medicine to Enhance Treatment Effectiveness"

[Asia Economy Reporter Hyunseok Yoo] Ybrain, an affiliate of Neofect, announced on the 16th that it is developing AI (artificial intelligence) technology that can be linked to electronic medicine. They plan to strengthen competitiveness in the electronic medicine market by applying AI technology to the electronic medicine for migraines, 'Dupang.'

Dupang is a non-drug migraine treatment device released by Ybrain in August this year. It is a migraine relief device attached to the forehead and is the first domestic company to receive marketing authorization from the Ministry of Food and Drug Safety. It stimulates the trigeminal nerve connected to the blood vessels related to headache pain to relieve migraine pain and reduce the frequency of attacks. It is characterized by faster effects and no tolerance compared to conventional chemical drugs.

In addition to stimulation therapy management, it records headache occurrence time, location, pain intensity, and triggers, and helps form healthy lifestyle habits through pattern analysis. It is lightweight and portable, allowing easy use anytime and anywhere.

Migraine is a chronic neurological disorder that occurs repeatedly, making management and prediction important. Ybrain plans to develop AI by analyzing accumulated data such as migraine triggers and migraine occurrence patterns. If this AI technology is installed in Dupang, it will be possible to manage migraine triggers, reduce the frequency and intensity of migraines, and predict the timing of migraine occurrence in advance to prepare accordingly.

A Ybrain official said, “As a result of analyzing data from 10,000 accumulated users of Dupang, the current migraine trigger prediction rate is 70%, and through this AI development, we expect to significantly improve migraine prediction accuracy in actual treatment situations,” adding, “It will become an essential item that can improve the quality of life for patients suffering from severe migraines.”

Meanwhile, since its launch, Dupang has received great attention by gaining positive reviews from actual users not only for its excellent therapeutic effects but also for its reasonable price and ease of use. Users who purchased Dupang said, “As a chronic migraine patient, the pain has definitely decreased and my head feels clearer,” and “Especially, the frequency of migraine attacks has noticeably decreased, so I actively recommend it to migraine patients.”

This content was produced with the assistance of AI translation services.